戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lines derived from eight genetically diverse founder lines.
2 although this was more variable in different founder lines.
3 orter gene and used to create six transgenic founder lines.
4  variable levels of expression in individual founder lines.
5 cDNA and utilized this transgene to generate founder lines.
6 tissues, including the thymus in some of the founder lines.
7 ric bud causes reduced branching in multiple founder lines.
8 lies; however, allelic effects differ across founder lines.
9 tween 3- and 50-fold higher depending on the founder line, and this occurred within 24-48 h after dos
10 rsensitive sites, is expressed in only a few founder lines, and expression is dysregulated in CD8(+)
11 derived from two independent TetOp-DeltaFosB founder lines but not in single NSE-tTA transgenic contr
12                               Study of three founder lines by FACS showed overexpression to varying e
13                                          The founder line carrying eight copies of this transgene has
14      The analysis of mice from six different founder lines demonstrated that this genomic DNA fragmen
15        WAP-h-Int3sh females from each of the founder lines develop mammary tumors, but with a long la
16       Although some transgenic mice from one founder line developed amyloidosis in the intestine, no
17                                          One founder line developed compound MTC/PTC at low frequency
18                              Some transgenic founder lines did not demonstrate reporter gene expressi
19                                   Two of the founder lines did not have a demonstrable phenotype (M-4
20 ary thyroid carcinoma (PTC) depending on the founder line examined.
21                        Two of six transgenic founder lines exhibited brain-selective expression of th
22                                   All tested founder lines exhibited red blood cell-specific expressi
23                                    All three founder lines exhibited strong suppression of IgE in res
24                                          The founder line exhibiting the highest level of suppression
25                  Twelve of twlve NPHS2 mouse founder lines expressed beta-gal exclusively in podocyte
26                                        Three founder lines expressed this transgene and constitutivel
27 2 generations of free recombination among 60 founder lines, following modification of the mating syst
28  DNA integrations in our genomic engineering founder lines for the purpose of generating complex knoc
29 ere human CD8 beta+ varied, depending on the founder line, from 4 to 88%, whereas the percentage amon
30                               In each of six founder lines, high-level luciferase activity was eviden
31 ckcrossed homozygous transgenic animals from founder line I had plasma PAI-1 levels of 23+/-12 ng/mL.
32 erminal repeat (MMTV-LTR) promoter, and four founder lines identified.
33            (5) Including observations on the founder lines in the QTL analysis should be avoided as i
34 in thymic lymphomas from multiple transgenic founder lines, including one line in which 15 of 15 prim
35  is produced in nonlymphoid tissues from all founder lines, including tissues that do not express end
36             Mammary gland development in all founder lines is normal and the females can lactate.
37            Formation of epiblast (EPI) - the founder line of all embryonic lineages - and extra-embry
38 6 -> Ser) was used to generate 15 transgenic founder lines of hA-IImon mice, that contained plasma hA
39 tively transferred into different transgenic founder lines of mice expressing HA as a peripheral self
40                        We generated multiple founder lines of mice with cardiac-restricted overexpres
41 ge number of contrasting RSA traits among 25 founder lines of the maize nested association mapping po
42 and B cells from three independently derived founder lines of transgenic mice bearing a recombined he
43 hematopoietic disease, we developed separate founder lines of transgenic mice, with the tetracycline
44                                              Founder line TgA, with the lowest level of IL-7 overexpr
45   In contrast, in the highest overexpressing founder line, TgB, alphabeta T-cell development was dist
46                             A transactivator founder line that strongly expressed PF4-driven tTA-vira
47 We generated two independent transgenic mice founder lines that express a stable variant of active hu
48                           In two independent founder lines, this -306 to +3 promoter region was suffi
49                                 Breeding two founder lines together produced mice with an activity of
50 evealed that one 570 kb YAC, in two separate founder lines, was associated with distinct learning def
51                               Two transgenic founder lines were generated and independently bred to s

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。